GlassScriptPhysician profile
Bradley D Gerber
NPI 1851390413
$22,158.48
in general payments reported to CMS, 2019-2025
13 companies · $2,144 in 2025
The $2,144 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $31.20 · 2021: $380 · 2022: $3,677 · 2023: $1,627 · 2024: $2,290 · 2025: $2,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,467 · Travel and Lodging: $2,595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,466.69 |
| Travel and Lodging | $2,594.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $11,653.33 | 2019-2022 | |
| Stryker Corporation | $3,637.43 | 2021-2025 | Mako, Triathlon, Insignia |
| Smith+Nephew, INC. | $3,018.94 | 2019-2025 | Or3o Dual Mobility, Legion Revision, Journey |
| Linvatec Corporation | $1,276.32 | 2022-2023 | Biobrace 23mm, Hall Power |
| Horizon Therapeutics Plc | $1,204.60 | 2019-2022 | |
| Arcuro Medical INC | $406.79 | 2025 | Superball |
| Ferring Pharmaceuticals INC. | $358.79 | 2019-2024 | Euflexxa |
| Depuy Synthes Sales INC. | $212.03 | 2019-2021 | |
| Polaris Technology Solutions LLC | $156.71 | 2024 | |
| Intellijoint Surgical INC. | $135.49 | 2019 | |
| Nuvasive, INC. | $56.94 | 2019-2020 | |
| Medical Device Business Services, INC. | $21.14 | 2023 | Velys |
| Zimmer Biomet Holdings, INC. | $19.97 | 2025 | G7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Gerber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.